 Anavex Life Sciences said its experimental Alzheimers treatment met the goals of a midstage study, leading AVXL stock to rocket early Friday. The post Anavex Catapults On Alzheimers Results But Math Question Clouds The Data appeared first on Investors Business Daily. 